Trial Profile
The role of Home packs of HIV Post-Exposure Prophylaxis for sexual exposure (PEPSE) to improve the speed and appropriate uptake of PEPSE in high risk individuals
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Maraviroc (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms HOME PEPSE
- 07 Jul 2021 Status changed from recruiting to completed.
- 30 Sep 2015 New trial record